Book Closure

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE140.000.75 (+0.54 %)
PREV CLOSE ( ) 139.25
OPEN PRICE ( ) 137.15
BID PRICE (QTY) 140.15 (11)
OFFER PRICE (QTY) 140.75 (117)
VOLUME 4816
TODAY'S LOW / HIGH ( )137.15 141.50
52 WK LOW / HIGH ( )113.55 202.2
NSE140.351.45 (+1.04 %)
PREV CLOSE( ) 138.90
OPEN PRICE ( ) 139.60
BID PRICE (QTY) 140.20 (10)
OFFER PRICE (QTY) 140.35 (13)
VOLUME 18667
TODAY'S LOW / HIGH( ) 139.60 141.60
52 WK LOW / HIGH ( )114.2 202.5

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.